118 related articles for article (PubMed ID: 17001472)
1. The chemokine (C-X-C motif) receptor 4 inhibitor AMD3100 accelerates blood flow restoration in diabetic mice.
Jiao C; Fricker S; Schatteman GC
Diabetologia; 2006 Nov; 49(11):2786-9. PubMed ID: 17001472
[TBL] [Abstract][Full Text] [Related]
2. CXCR4 antagonist AMD3100 accelerates impaired wound healing in diabetic mice.
Nishimura Y; Ii M; Qin G; Hamada H; Asai J; Takenaka H; Sekiguchi H; Renault MA; Jujo K; Katoh N; Kishimoto S; Ito A; Kamide C; Kenny J; Millay M; Misener S; Thorne T; Losordo DW
J Invest Dermatol; 2012 Mar; 132(3 Pt 1):711-20. PubMed ID: 22048734
[TBL] [Abstract][Full Text] [Related]
3. CXCR4 antagonist delivery on decellularized skin scaffold facilitates impaired wound healing in diabetic mice by increasing expression of SDF-1 and enhancing migration of CXCR4-positive cells.
Liu H; Liu H; Deng X; Chen M; Han X; Yan W; Wang N
Wound Repair Regen; 2017 Aug; 25(4):652-664. PubMed ID: 28783870
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of CXCR-4 and adhesion molecule expression during autologous stem cell mobilisation with G-CSF plus AMD3100 in patients with multiple myeloma.
Oelschlaegel U; Bornhauser M; Boxberger S; Kroschinsky F; Illmer T; Hoelig K; Calandra G; Ehninger G; Platzbecker U
Ann Hematol; 2007 Aug; 86(8):569-73. PubMed ID: 17437111
[TBL] [Abstract][Full Text] [Related]
5. Synergistic vasculogenic effects of AMD3100 and stromal-cell-derived factor-1α in vasa nervorum of the sciatic nerve of mice with diabetic peripheral neuropathy.
Kim BJ; Lee JK; Schuchman EH; Jin HK; Bae JS
Cell Tissue Res; 2013 Nov; 354(2):395-407. PubMed ID: 23942895
[TBL] [Abstract][Full Text] [Related]
6. Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor.
Hess DA; Bonde J; Craft TP; Wirthlin L; Hohm S; Lahey R; Todt LM; Dipersio JF; Devine SM; Nolta JA
Biol Blood Marrow Transplant; 2007 Apr; 13(4):398-411. PubMed ID: 17382247
[TBL] [Abstract][Full Text] [Related]
7. Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis.
Gadau S; Emanueli C; Van Linthout S; Graiani G; Todaro M; Meloni M; Campesi I; Invernici G; Spillmann F; Ward K; Madeddu P
Diabetologia; 2006 Feb; 49(2):405-20. PubMed ID: 16416271
[TBL] [Abstract][Full Text] [Related]
8. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist.
Broxmeyer HE; Orschell CM; Clapp DW; Hangoc G; Cooper S; Plett PA; Liles WC; Li X; Graham-Evans B; Campbell TB; Calandra G; Bridger G; Dale DC; Srour EF
J Exp Med; 2005 Apr; 201(8):1307-18. PubMed ID: 15837815
[TBL] [Abstract][Full Text] [Related]
9. Improved mobilization of peripheral blood CD34+ cells and dendritic cells by AMD3100 plus granulocyte-colony-stimulating factor in non-Hodgkin's lymphoma patients.
Gazitt Y; Freytes CO; Akay C; Badel K; Calandra G
Stem Cells Dev; 2007 Aug; 16(4):657-66. PubMed ID: 17784839
[TBL] [Abstract][Full Text] [Related]
10. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice.
Schatteman GC; Hanlon HD; Jiao C; Dodds SG; Christy BA
J Clin Invest; 2000 Aug; 106(4):571-8. PubMed ID: 10953032
[TBL] [Abstract][Full Text] [Related]
11. Angiogenic peptides improve blood flow and promote capillary growth in a diabetic and ischaemic mouse model.
Raiter A; Bechor Z; Kleiman M; Leshem-Lev D; Battler A; Hardy B
Eur J Vasc Endovasc Surg; 2010 Sep; 40(3):381-8. PubMed ID: 20226697
[TBL] [Abstract][Full Text] [Related]
12. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist.
Liles WC; Broxmeyer HE; Rodger E; Wood B; Hübel K; Cooper S; Hangoc G; Bridger GJ; Henson GW; Calandra G; Dale DC
Blood; 2003 Oct; 102(8):2728-30. PubMed ID: 12855591
[TBL] [Abstract][Full Text] [Related]
13. Chemokine (C-X-C motif) receptor 4 blockade by AMD3100 inhibits experimental abdominal aortic aneurysm expansion through anti-inflammatory effects.
Michineau S; Franck G; Wagner-Ballon O; Dai J; Allaire E; Gervais M
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1747-55. PubMed ID: 24876351
[TBL] [Abstract][Full Text] [Related]
14. Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma.
Devine SM; Flomenberg N; Vesole DH; Liesveld J; Weisdorf D; Badel K; Calandra G; DiPersio JF
J Clin Oncol; 2004 Mar; 22(6):1095-102. PubMed ID: 15020611
[TBL] [Abstract][Full Text] [Related]
15. Nerve growth factor supplementation reverses the impairment, induced by Type 1 diabetes, of hindlimb post-ischaemic recovery in mice.
Salis MB; Graiani G; Desortes E; Caldwell RB; Madeddu P; Emanueli C
Diabetologia; 2004 Jun; 47(6):1055-63. PubMed ID: 15184980
[TBL] [Abstract][Full Text] [Related]
16. AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates.
Larochelle A; Krouse A; Metzger M; Orlic D; Donahue RE; Fricker S; Bridger G; Dunbar CE; Hematti P
Blood; 2006 May; 107(9):3772-8. PubMed ID: 16439684
[TBL] [Abstract][Full Text] [Related]
17. Nerve growth factor gene therapy improves bone marrow sensory innervation and nociceptor-mediated stem cell release in a mouse model of type 1 diabetes with limb ischaemia.
Dang Z; Avolio E; Albertario A; Sala-Newby GB; Thomas AC; Wang N; Emanueli C; Madeddu P
Diabetologia; 2019 Jul; 62(7):1297-1311. PubMed ID: 31016359
[TBL] [Abstract][Full Text] [Related]
18. Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice.
Moriya J; Wu X; Zavala-Solorio J; Ross J; Liang XH; Ferrara N
J Vasc Surg; 2014 May; 59(5):1402-9.e1-4. PubMed ID: 23856609
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin pretreatment enhances ischemia-induced neovascularization and blood flow recovery in streptozotocin-treated mice.
Huang PH; Chen JY; Chen CY; Chen JW; Lin SJ; Shih CC
J Vasc Surg; 2016 Oct; 64(4):1112-1120.e1. PubMed ID: 26830691
[TBL] [Abstract][Full Text] [Related]
20. Structural analogues of AMD3100 mobilise haematopoietic progenitor cells from bone marrow in vivo according to their ability to inhibit CXCL12 binding to CXCR4 in vitro.
Martin C; Bridger GJ; Rankin SM
Br J Haematol; 2006 Aug; 134(3):326-9. PubMed ID: 16787495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
